Cargando…
Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930024/ http://dx.doi.org/10.1016/S2666-6367(22)00655-8 |
| _version_ | 1784670971871887360 |
|---|---|
| author | Faisal, Muhammad Salman Saad, Ayman Mims, Alice Vasu, Sumithira Wall, Sarah A. Larkin, Karilyn Choe, Hannah Brammer, Jonathan E. Penza, Sam Jaglowski, Samantha De Lima, Marcos |
| author_facet | Faisal, Muhammad Salman Saad, Ayman Mims, Alice Vasu, Sumithira Wall, Sarah A. Larkin, Karilyn Choe, Hannah Brammer, Jonathan E. Penza, Sam Jaglowski, Samantha De Lima, Marcos |
| author_sort | Faisal, Muhammad Salman |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8930024 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89300242022-03-18 Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection Faisal, Muhammad Salman Saad, Ayman Mims, Alice Vasu, Sumithira Wall, Sarah A. Larkin, Karilyn Choe, Hannah Brammer, Jonathan E. Penza, Sam Jaglowski, Samantha De Lima, Marcos Transplant Cell Ther Poster Session - Infectious Diseases and Cytotoxic T Lymphocytes American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. 2022-03 2022-03-18 /pmc/articles/PMC8930024/ http://dx.doi.org/10.1016/S2666-6367(22)00655-8 Text en Copyright © 2022 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Session - Infectious Diseases and Cytotoxic T Lymphocytes Faisal, Muhammad Salman Saad, Ayman Mims, Alice Vasu, Sumithira Wall, Sarah A. Larkin, Karilyn Choe, Hannah Brammer, Jonathan E. Penza, Sam Jaglowski, Samantha De Lima, Marcos Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection |
| title | Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection |
| title_full | Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection |
| title_fullStr | Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection |
| title_full_unstemmed | Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection |
| title_short | Bamlanivimab Monoclonal Antibody Treatment in Patients with Graft Versus Host Disease (GVHD) Diagnosed with COVID-19 Infection |
| title_sort | bamlanivimab monoclonal antibody treatment in patients with graft versus host disease (gvhd) diagnosed with covid-19 infection |
| topic | Poster Session - Infectious Diseases and Cytotoxic T Lymphocytes |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930024/ http://dx.doi.org/10.1016/S2666-6367(22)00655-8 |
| work_keys_str_mv | AT faisalmuhammadsalman bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection AT saadayman bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection AT mimsalice bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection AT vasusumithira bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection AT wallsaraha bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection AT larkinkarilyn bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection AT choehannah bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection AT brammerjonathane bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection AT penzasam bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection AT jaglowskisamantha bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection AT delimamarcos bamlanivimabmonoclonalantibodytreatmentinpatientswithgraftversushostdiseasegvhddiagnosedwithcovid19infection |